Camden Capital »

West Pharmaceutical Services shares owned by Camden Capital

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by Camden Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $261k 740 352.05
2021-12-31 $207k 441 469.39
2021-06-30 $200k 558 358.42

More positions owned by Camden Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Floatng Rat Trea (USFR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
General Electric Com New (GE)
New York Community Ban (NYCB)
Citigroup Com New (C)
Micron Technology (MU)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Chevron Corporation (CVX)
Bank of America Corporation (BAC)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)

View all positions for Camden Capital

Top funds holding West Pharmaceutical Services

Vanguard Group
Bank of New York Mellon
T. Rowe Price Associates
Franklin Resources
Artisan Partners Limited Partnership
Brown Advisory Holdings Incorporated
Durable Capital Partners
Bamco
Citadel Advisors
Jpmorgan Chase & Co
Norges Bank Investment Management
Massachusetts Financial Services
Alliancebernstein
Legal & General Group
TD Asset Management

View all funds holding West Pharmaceutical Services